Researchers at Johns Hopkins Medicine have developed a drug to treat Alzheimer’s disease, schizophrenia and sickle cell disease.

A drug first developed to treat Alzheimer’s disease and sickle cell disease reduces obesity, fatty liver and improves heart function.

Drug first developed to treat Alzheimer’s disease, schizophrenia and sickle cell disease reduces obesity, and improves heart function.

Researchers have found that a drug first developed to treat Alzheimer’s disease reduces obesity and fatty liver and improves heart function.

Researchers have found that a drug first developed to treat Alzheimer’s disease, schizophrenia and sickle cell disease reduces obesity.